Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine
- 1 July 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (13) , 1137-1147
- https://doi.org/10.1038/sj.gt.3301220
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 40 references indexed in Scilit:
- Linear Differentiation of Cytotoxic Effectors into Memory T LymphocytesScience, 1999
- Superiority of the ear pinna over muscle tissue as site for DNA vaccinationGene Therapy, 1998
- Naked DNA – the poor man’s gene therapy?Gene Therapy, 1998
- Dendritic Cells, Interleukin 12, and CD4+ Lymphocytes in the Initiation of Class l-restricted Reactivity to a Tumor/Self PeptideCritical Reviews in Immunology, 1998
- DNA VACCINESAnnual Review of Immunology, 1997
- Scattered micrometastases visualized at the single‐cell level: Detection and re‐isolation of lacZ‐labeled metastasized lymphoma cellsInternational Journal of Cancer, 1994
- Cytotoxic T-cell memory without antigenNature, 1994
- In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti‐tumor cytotoxic T lymphocytesEuropean Journal of Immunology, 1991
- Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.The Journal of Experimental Medicine, 1990
- CD4+ helper T cells are required for resistance to a highly metastatic murine tumorEuropean Journal of Immunology, 1987